BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 15857605)

  • 1. Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.
    Chao MN; Matiuzzi CE; Storey M; Li C; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
    ChemMedChem; 2015 Jun; 10(6):1094-108. PubMed ID: 25914175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A
    Campagnaro GD; Elati HAA; Balaska S; Martin Abril ME; Natto MJ; Hulpia F; Lee K; Sheiner L; Van Calenbergh S; de Koning HP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054895
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.
    McFarland MM; Zach SJ; Wang X; Potluri LP; Neville AJ; Vennerstrom JL; Davis PH
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7017-7034. PubMed ID: 27600037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.
    Naguib FN; Rais RH; Al Safarjalani ON; el Kouni MH
    Comp Biochem Physiol B Biochem Mol Biol; 2015 Oct; 188():63-9. PubMed ID: 26112826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine kinase: exploitation for therapeutic gain.
    Boison D
    Pharmacol Rev; 2013 Jul; 65(3):906-43. PubMed ID: 23592612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; El Kouni MH
    Biochem Pharmacol; 2010 Oct; 80(7):955-63. PubMed ID: 20541538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting purine and pyrimidine metabolism in human apicomplexan parasites.
    Hyde JE
    Curr Drug Targets; 2007 Jan; 8(1):31-47. PubMed ID: 17266529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecules targeting the purine salvage pathway in Apicomplexan parasites.
    Ghérardi A; Sarciron ME
    Trends Parasitol; 2007 Aug; 23(8):384-9. PubMed ID: 17574921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Rais RH; Al Safarjalani ON; Yadav V; Guarcello V; Kirk M; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2005 May; 69(10):1409-19. PubMed ID: 15857605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
    Yadav V; Chu CK; Rais RH; Al Safarjalani ON; Guarcello V; Naguib FN; el Kouni MH
    J Med Chem; 2004 Apr; 47(8):1987-96. PubMed ID: 15055998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    J Med Chem; 2008 Jul; 51(13):3934-45. PubMed ID: 18563892
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.